U.S. Markets closed

Grifols, S.A. (GRF.MC)

MCE - MCE Delayed Price. Currency in EUR
Add to watchlist
24.130.00 (0.00%)
At close: 5:35PM CET
Sign in to post a message.
  • A
    Amy B.
    Chat setup seems perfect for a breakout.. beautiful ascending triangle
    Bullish
  • G
    Gary
    i like this company but it seems to stagnate. the price should be moving higher. ..
  • D
    Donna
    hares in Spanish pharmaceutical company Grifols lead Spain's IBEX 35 after U.S. rival Vertex stopped development of an experimental therapy aimed at treating Alpha-1 antitrypsinase deficiency. Sabadell says the news is very positive for Grifols, as the Vertex candidate posed a possible competitive threat to its market-leading product Prolastin. Grifols shares climb 7.5%.
  • l
    leonard
    GRFS. is in a good position as the largest plasma collector and already has a contract with BARDA:

    https://www.jwatch.org/

    Early Results Promising for Convalescent Plasma for COVID-19

    By Kelly Young

    Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

    A small, preliminary case series in JAMA shows promise for using convalescent plasma to treat critically ill patients with novel coronavirus disease (COVID-19).

    Researchers in China treated five COVID-19 patients who required mechanical ventilation and had severe pneumonia and high viral load despite taking antivirals. Plasma donors had recovered from SARS-CoV-2 infection and had been symptom-free for at least 10 days. Recipients received 400 mL of convalescent plasma containing neutralizing antibody.

    Within a day of the transfusion, markers of viral load began to improve. All patients saw gradual resolution of pulmonary lesions within 3 days. By day 9, four patients no longer required respiratory support. Three of the patients had been discharged after stays of roughly 50 days. The other two were still hospitalized.

    The authors and editorialists note that the results need to be validated in clinical trials. Last week, the FDA allowed physicians to apply for emergency use of investigational convalescent plasma to treat individual patients.

    LINK(S):

    JAMA article on convalescent plasma (Free)

    JAMA editorial (Free)

    FDA information on investigational convalescent plasma (Free)

    NEJM COVID-19 page (Free)
    NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
    NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
    www.jwatch.org
    Bullish
  • l
    leonard
    Big article in STAT yesterday that the US multi-institutional consortium study on the benefits of convalescent plasma for sick patients with CV19 was strongly suggestive of efficacy; unfortunately, it was not a randomized placebo controlled study. The formal paper is awaiting publication. Under BARDA auspices, convalescent plasma is being converted into immunoglobulin(powder) which enables standardization from batch to batch, and allows for easier storage and administration. The GRFS product has already begun a ph3 study for CV19, both for prophylaxis for exposed individuals and as Rx for sick patients. The chances of success are excellent. The purest play on this theme is GRFS, which is a 15bil market cap biomedical company which specializes in plasma collection and plasma based theraputics. GRFS is one of the few biomedical companies which has failed to get a boost from CV19 and a +ph3 study almost certainly will lead to explosive growth. I am a heavy buyer today. Incidentally, I am a hematologist who did 2 years of immunology research on antibody therapy at NIH
    Bullish
  • A
    Alfonso
    I think this will go up tomorrow due to Trumps FDA plasma news
  • O
    O
    President Donald Trump on Sunday will announce the emergency authorization of convalescent plasma for Covid-19, according to the Washington Post and other reports.
    President Donald Trump on Sunday will announce the emergency authorization of convalescent plasma for Covid-19, according to the Washington Post and other reports.
    www.cnbc.com
  • G
    Gary
    some companies trading at nosebleed levels .this company is cheaply priced. why does it go lower? no sense at all
  • R
    RigDownTex
    WSJ article - Convalescent Plasma Is Safe to Treat Covid-19, National Study Shows
    A study of thousands of Covid-19 patients who received blood plasma transfusions from recovered patients indicates the experimental therapy appears to be safe, paving the way for futurenational-study-finds-convalescent-plasma-to-treat-covid-19-is-safe-11589453869 studies and clinical trials, so says WSJ article.
    https://www.wsj.com/articles/national-study-finds-convalescent-plasma-to-treat-covid-19-is-safe-11589453869
    A study of thousands of Covid-19 patients who received blood plasma transfusions from recovered patients indicates the experimental therapy appears to be safe, paving the way for future studies and clinical trials.
    A study of thousands of Covid-19 patients who received blood plasma transfusions from recovered patients indicates the experimental therapy appears to be safe, paving the way for future studies and clinical trials.
    www.wsj.com
    Bullish
  • S
    SEVEN
    20.07 cometh to papa
  • B
    Burle
    Reached March Lows... Positive that this is reversal point for this stock.
  • A
    Akeroyd
    I’ve been day trading for years and I’m so glad I finally found http://dailystox.xyz. They’re pre-market watchlists cover all the latest market-moving news, and they don’t beat you down with tons of ads. Highly recommend!
  • Y
    Yahoo Finance Insights
    GRFS is up 6.83% to 17.83
  • R
    RigDownTex
    Question, using Convalescent Plasma on non infected High Risk Caregivers?
    I wondering if there's any information or study on this, seems to me this might work if the anti-bodies help those who are severely afflicted with COVID-19 perhaps this would give them some increased protection past the PPE paraphernalia. Obviously I'm just a layman here, just thinking out loud.....
    Bullish
  • Y
    Yahoo Finance Insights
    GRFS is up 4.92% to 21.32
  • R
    Revvers
    What's with the 6+% drop today?
  • Y
    Yahoo Finance Insights
    GRFS reached a new 52 Week Low at $18.51
  • Y
    Yahoo Finance Insights
    GRFS reached a new 52 Week Low at $19.45
  • Y
    Yahoo Finance Insights
    GRFS reached a new 52 Week Low at $19.24
  • S
    SENOR BALTIMORE
    get out now, if you still can ...................